Sun Pharma’s Halol Plant Gets 8 US FDA Observations After Inspection Ends on June 13
Sun Pharmaceutical Industries Ltd’s Halol plant in Gujarat has received eight observations from the US Food and Drug Administration (US FDA) after a recent inspection. The inspection was conducted between June 2 and June 13, 2025, as per the company’s official filing. The US FDA issued a Form 483 which means the inspection team saw […]
Sun Pharma’s Halol Plant Gets 8 US FDA Observations After Inspection Ends on June 13 Read More »